ESTIMATION OF CARDIOVASCULAR RISK IN PATIENTS WITH ULCERATIVE COLITIS ENROLLED IN UPADACITINIB PHASE 3 CLINICAL TRIALS

Raymond Cross  1     Kara M. De Felice  2     Dapo Ilo  3     Benjamin Duncan  3     Jinghui Liu  4     Cecile T. J. Holweg  4     Reezwana Chowdhury  5    
1 University of Maryland, Baltimore, United States
2 University of Cincinnati, Cincinnati, United States
3 AbbVie, Inc., North Chicago, United States
4 Everest Clinical Research, Little Falls, United States
5 John Hopkins University, Baltimore, United States

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing